Écrit par Novozymes | 21 Janvier 2013

COPENHAGEN, DENMARK – January 21, 2013 - Novozymes, the world leader in bioinnovation and industrial enzymes, today reported 7% sales growth in 2012 compared with 2011. EBIT increased by 17%, raising the EBIT margin to 24.4%. Net profit grew by 10%. Strong free cash flow before acquisitions of DKK 1,581 million exceeded the outlook. For 2013, the EBIT margin is expected to remain at its...

Écrit par Novozymes | 21 Janvier 2013

COPENHAGEN, DENMARK – January 21, 2013 - The Board of Directors of Novozymes has appointed Peder Holk Nielsen as President and Chief Executive Officer with effect from April 1, 2013.“I am pleased to announce that Peder Holk Nielsen will succeed Steen Riisgaard as President and Chief Executive Officer,” says Henrik Gürtler, Chairman of the Board at Novozymes. “Peder Holk Nielsen’s...

Écrit par CICR | 20 Janvier 2013

Yangon/Genève (CICR) – Le président du Comité international de la Croix-Rouge (CICR), Peter Maurer, a achevé aujourd’hui la première visite d’un président du CICR au Myanmar. M. Maurer a rencontré le président de l’Union Thein Sein, les ministres de l'Intérieur, des Affaires étrangères et de la Défense, les présidents des deux chambres du Parlement, les dirigeants de deux...

Écrit par WHO | 19 Janvier 2013

WHO/Statement WHO WELCOMES INTERNATIONAL TREATY ON MERCURY The World Health Organization (WHO) today welcomes of the approval of a new international convention* that will reduce the harmful health effects of mercury. Mercury is recognized as a chemical of global concern due to its ability to travel long distances in the atmosphere; its persistence in the environment; its ability to...